--- 
title: "Chapter_2" 
author: "Philippe Glaziou, Pete Dodd" 
date: "2021-10-12" 
output:  
  html_fragment: 
    # Don’t include a table of contents 
    toc: no 
    # Set standard figure width to 12 inches 
    fig_width: 12 
    # Don’t write figure captions 
    fig_caption: FALSE 
--- 











<a name="table-2-2-1"></a>

### <span style="color:#F21905">Table 2.2.1</span> Global and regional estimates of TB mortality, numbers (in thousands) and rates (per 100 000 population) in 2020
<table id="burden_num_table">
 <thead>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="1"></th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="6"><div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">Number of deaths (in thousands)</div></th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="6"><div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">Rate per 100 000 population</div></th>
</tr>
<tr>
<th style="empty-cells: hide;border-bottom:hidden;" colspan="1"></th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="3"><div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">HIV-negative</div></th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="3"><div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">HIV-positive</div></th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="3"><div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">HIV-negative</div></th>
<th style="border-bottom:hidden;padding-bottom:0; padding-left:3px;padding-right:3px;text-align: center; " colspan="3"><div style="border-bottom: 1px solid #ddd; padding-bottom: 5px; ">HIV-positive</div></th>
</tr>
  <tr>
   <th style="text-align:right;"> Region or country group </th>
   <th style="text-align:center;"> Best estimate </th>
   <th style="text-align:center;"> Low </th>
   <th style="text-align:center;"> High </th>
   <th style="text-align:center;"> Best estimate </th>
   <th style="text-align:center;"> Low </th>
   <th style="text-align:center;"> High </th>
   <th style="text-align:center;"> Best estimate </th>
   <th style="text-align:center;"> Low </th>
   <th style="text-align:center;"> High </th>
   <th style="text-align:center;"> Best estimate </th>
   <th style="text-align:center;"> Low </th>
   <th style="text-align:center;"> High </th>
  </tr>
 </thead>
<tbody>
  <tr>
   <td style="text-align:right;"> African Region </td>
   <td style="text-align:center;"> 379 </td>
   <td style="text-align:center;"> 321 </td>
   <td style="text-align:center;"> 441 </td>
   <td style="text-align:center;"> 170 </td>
   <td style="text-align:center;"> 144 </td>
   <td style="text-align:center;"> 199 </td>
   <td style="text-align:center;"> 34 </td>
   <td style="text-align:center;"> 29 </td>
   <td style="text-align:center;"> 39 </td>
   <td style="text-align:center;"> 15 </td>
   <td style="text-align:center;"> 13 </td>
   <td style="text-align:center;"> 18 </td>
  </tr>
  <tr>
   <td style="text-align:right;"> Region of the Americas </td>
   <td style="text-align:center;"> 19 </td>
   <td style="text-align:center;"> 18 </td>
   <td style="text-align:center;"> 20 </td>
   <td style="text-align:center;"> 7.9 </td>
   <td style="text-align:center;"> 7.2 </td>
   <td style="text-align:center;"> 8.7 </td>
   <td style="text-align:center;"> 1.9 </td>
   <td style="text-align:center;"> 1.8 </td>
   <td style="text-align:center;"> 2.0 </td>
   <td style="text-align:center;"> 0.77 </td>
   <td style="text-align:center;"> 0.70 </td>
   <td style="text-align:center;"> 0.85 </td>
  </tr>
  <tr>
   <td style="text-align:right;"> Eastern Mediterranean Region </td>
   <td style="text-align:center;"> 80 </td>
   <td style="text-align:center;"> 68 </td>
   <td style="text-align:center;"> 92 </td>
   <td style="text-align:center;"> 2.9 </td>
   <td style="text-align:center;"> 2.5 </td>
   <td style="text-align:center;"> 3.3 </td>
   <td style="text-align:center;"> 11 </td>
   <td style="text-align:center;"> 9.3 </td>
   <td style="text-align:center;"> 13 </td>
   <td style="text-align:center;"> 0.39 </td>
   <td style="text-align:center;"> 0.34 </td>
   <td style="text-align:center;"> 0.46 </td>
  </tr>
  <tr>
   <td style="text-align:right;"> European Region </td>
   <td style="text-align:center;"> 21 </td>
   <td style="text-align:center;"> 20 </td>
   <td style="text-align:center;"> 22 </td>
   <td style="text-align:center;"> 5.4 </td>
   <td style="text-align:center;"> 5.0 </td>
   <td style="text-align:center;"> 5.9 </td>
   <td style="text-align:center;"> 2.3 </td>
   <td style="text-align:center;"> 2.2 </td>
   <td style="text-align:center;"> 2.4 </td>
   <td style="text-align:center;"> 0.58 </td>
   <td style="text-align:center;"> 0.53 </td>
   <td style="text-align:center;"> 0.63 </td>
  </tr>
  <tr>
   <td style="text-align:right;"> South-East Asia Region </td>
   <td style="text-align:center;"> 698 </td>
   <td style="text-align:center;"> 650 </td>
   <td style="text-align:center;"> 747 </td>
   <td style="text-align:center;"> 21 </td>
   <td style="text-align:center;"> 19 </td>
   <td style="text-align:center;"> 23 </td>
   <td style="text-align:center;"> 35 </td>
   <td style="text-align:center;"> 32 </td>
   <td style="text-align:center;"> 37 </td>
   <td style="text-align:center;"> 1.1 </td>
   <td style="text-align:center;"> 0.96 </td>
   <td style="text-align:center;"> 1.1 </td>
  </tr>
  <tr>
   <td style="text-align:right;"> Western Pacific Region </td>
   <td style="text-align:center;"> 87 </td>
   <td style="text-align:center;"> 80 </td>
   <td style="text-align:center;"> 93 </td>
   <td style="text-align:center;"> 5.9 </td>
   <td style="text-align:center;"> 4.9 </td>
   <td style="text-align:center;"> 6.9 </td>
   <td style="text-align:center;"> 4.5 </td>
   <td style="text-align:center;"> 4.1 </td>
   <td style="text-align:center;"> 4.8 </td>
   <td style="text-align:center;"> 0.30 </td>
   <td style="text-align:center;"> 0.25 </td>
   <td style="text-align:center;"> 0.36 </td>
  </tr>
  <tr>
   <td style="text-align:right;"> High TB burden countries </td>
   <td style="text-align:center;"> 1 110 </td>
   <td style="text-align:center;"> 1 030 </td>
   <td style="text-align:center;"> 1 190 </td>
   <td style="text-align:center;"> 166 </td>
   <td style="text-align:center;"> 139 </td>
   <td style="text-align:center;"> 194 </td>
   <td style="text-align:center;"> 23 </td>
   <td style="text-align:center;"> 22 </td>
   <td style="text-align:center;"> 25 </td>
   <td style="text-align:center;"> 3.4 </td>
   <td style="text-align:center;"> 2.9 </td>
   <td style="text-align:center;"> 4.0 </td>
  </tr>
  <tr>
   <td style="text-align:right;"> Global </td>
   <td style="text-align:center;"> 1 280 </td>
   <td style="text-align:center;"> 1 210 </td>
   <td style="text-align:center;"> 1 360 </td>
   <td style="text-align:center;"> 214 </td>
   <td style="text-align:center;"> 187 </td>
   <td style="text-align:center;"> 242 </td>
   <td style="text-align:center;"> 17 </td>
   <td style="text-align:center;"> 16 </td>
   <td style="text-align:center;"> 18 </td>
   <td style="text-align:center;"> 2.7 </td>
   <td style="text-align:center;"> 2.4 </td>
   <td style="text-align:center;"> 3.1 </td>
  </tr>
</tbody>
</table>
<div class="footnote">
Low and high are the 5th and 95th percentiles of the uncertainty interval (UI)
</div>






<a name="fig--2-2-1"></a>

### <span style="color:#F21905">Fig. 2.2.1</span> Global trends in the estimated number of TB deaths (left) and the mortality rate (right), 2000&#8211;2020 
<span class="subhead">Shaded areas represent uncertainty intervals. The horizontal dashed line shows the 2020 milestone of the End TB Strategy.</span> 

<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.1-1.png" title="Global trends in the estimated number of TB deaths (left) and the mortality rate (right), 2000-2020" alt="Global trends in the estimated number of TB deaths (left) and the mortality rate (right), 2000-2020" width="1152" />
 





<a name="fig--2-2-2"></a>

### <span style="color:#F21905">Fig. 2.2.2</span> Top causes of death worldwide in 2019^a,b^
<span class="subhead">Deaths from TB among HIV-positive people are shown in grey.</span>

<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.2-1.png" title="Top causes of death worldwide in 2019" alt="Top causes of death worldwide in 2019" width="1152" />
<div class="footnote"> ^a^ This is the latest year for which estimates for all causes are currently available. See WHO estimates, available at https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death.<br>
^b^ Deaths from TB among HIV-positive people are officially classified as deaths caused by HIV/AIDS in the International Classification of Diseases. </div> 






<a name="fig--2-2-3"></a>

### <span style="color:#F21905">Fig. 2.2.3</span> Estimated number of deaths from HIV/AIDS and TB in 2020^a,b^ 
<span class="subhead">Deaths from TB among HIV-positive people are shown in grey.</span>
<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.3-1.png" title="Estimated number of deaths from HIV/AIDS and TB in 2020" alt="Estimated number of deaths from HIV/AIDS and TB in 2020" width="1152" />
<div class="footnote"> ^a^ For HIV/AIDS, the latest estimates of the number of deaths in 2020 that have been published by UNAIDS are available at http://www.unaids.org/en/ (accessed 16 August 2021). For TB, the estimates for 2020 are those published in this report.<br>
^b^ Deaths from TB among HIV-positive people are officially classified as deaths caused by HIV/AIDS in the International Classification of Diseases.</div> 





<a name="fig--2-2-4"></a> 

### <span style="color:#F21905">Fig. 2.2.4</span> Global trends in the estimated number of deaths caused by TB and HIV (in millions), 2000&#8211;2020^a,b^
<span class="subhead">Shaded areas represent uncertainty intervals.</span> 

<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.4-1.png" title="Global trends in the estimated number of deaths caused by TB and HIV (in millions), 2000–2020" alt="Global trends in the estimated number of deaths caused by TB and HIV (in millions), 2000–2020" width="1152" />
<div class="footnote"> ^a^ For HIV/AIDS, the latest estimates of the number of deaths in 2020 that have been published by UNAIDS are available at http://www.unaids.org/en/ (accessed 16 August 2021). For TB, the estimates for 2020 are those published in this report.<br>
^b^ Deaths from TB among HIV-positive people are officially classified as deaths caused by HIV/AIDS in the International Classification of Diseases.</div> 



<a name="fig--2-2-5"></a>

### <span style="color:#F21905">Fig. 2.2.5</span> Trends in estimated TB mortality rates by WHO region, 2000&#8211;2020
<span class="subhead">Estimated TB mortality rates among HIV-negative people are shown in <span style="color:#3232ff">blue</span> and estimated mortality rates among HIV-positive people are shown in <span style="color:#87ceeb">light blue</span>. Shaded areas represent uncertainty intervals.</span> 

<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.5-1.png" title="Trends in estimated TB mortality rates by WHO region, 2000-2020" alt="Trends in estimated TB mortality rates by WHO region, 2000-2020" width="1152" />





<a name="fig--2-2-6"></a> 

### <span style="color:#F21905">Fig. 2.2.6</span> Trends in the estimated absolute number of TB deaths (HIV-positive and HIV-negative, in thousands) by WHO region, 2000&#8211;2020 
<span class="subhead">Shaded areas represent uncertainty intervals. The horizontal dashed line shows the 2020 milestone of the End TB Strategy.</span> 
<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.6-1.png" title="Trends in the estimated absolute number of TB deaths (HIV-positive and HIV-negative, in thousands) by WHO region, 2000-2020" alt="Trends in the estimated absolute number of TB deaths (HIV-positive and HIV-negative, in thousands) by WHO region, 2000-2020" width="1152" />







<a name="fig--2-2-7a"></a> 

### <span style="color:#F21905">Fig. 2.2.7a</span> Trends in the estimated absolute number (in thousands) of TB deaths (HIV-positive and HIV-negative TB) in the 30 high TB burden countries, 2000&#8211;2020
<span class="subhead">Shaded areas represent uncertainty intervals. The horizontal dashed line shows the 2020 milestone of the End TB Strategy.</span> 
<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.7a-1.png" title="Trends in the estimated absolute number of TB deaths (HIV-positive and HIV-negative TB) in the 30 high TB burden countries, 2000-2020" alt="Trends in the estimated absolute number of TB deaths (HIV-positive and HIV-negative TB) in the 30 high TB burden countries, 2000-2020" width="1152" />






<a name="fig--2-2-7b"></a>

### <span style="color:#F21905">Fig. 2.2.7b</span> Trends in the estimated absolute number (in thousands) of TB deaths (HIV-positive and HIV-negative TB) in the 3 global TB watchlist countries, 2000&#8211;2020
<span class="subhead">Shaded areas represent uncertainty intervals. The horizontal dashed line shows the 2020 milestone of the End TB Strategy.</span> 
<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.7b-1.png" title="Trends in the estimated absolute number of TB deaths (HIV-positive and HIV-negative TB) in the 3 WHO watch-list countries, 2000-2020" alt="Trends in the estimated absolute number of TB deaths (HIV-positive and HIV-negative TB) in the 3 WHO watch-list countries, 2000-2020" width="768" style="display: block; margin: auto auto auto 0;" />




 



<a name="fig--2-2-8"></a> 

### <span style="color:#F21905">Fig. 2.2.8</span> Estimated TB mortality rates in HIV-negative people, 2020

<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.8-1.png" title="Estimated TB mortality rates in HIV-negative people, 2020" alt="Estimated TB mortality rates in HIV-negative people, 2020" width="1152" />





 
 
 
 


<a name="fig--2-2-9"></a>

### <span style="color:#F21905">Fig. 2.2.9</span> Estimates of the case fatality ratio (CFR), including HIV-negative and HIV-positive people, 2020

<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.9-1.png" title="Case fatality ratio (2020)" alt="Case fatality ratio (2020)" width="1152" />






<a name="fig--2-2-10a"></a>

### <span style="color:#F21905">Fig. 2.2.10a</span> Global distribution of estimated TB mortality in HIV-negative people by age group and sex (female in <span style="color:#951b81">purple</span>; male in <span style="color:#80a51b">green</span>), 2020 

<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.10a-1.png" title="Main methods used to estimate TB mortality in HIV-negative people" alt="Main methods used to estimate TB mortality in HIV-negative people" width="1152" />








<a name="fig--2-2-10b"></a>

### <span style="color:#F21905">Fig. 2.2.10b</span> Regional distribution of estimated TB mortality in HIV-negative people by age group and sex (female in <span style="color:#951b81">purple</span>; male in <span style="color:#80a51b">green</span>), 2020

<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.10b-1.png" title="Main methods used to estimate TB mortality in HIV-negative people" alt="Main methods used to estimate TB mortality in HIV-negative people" width="1152" />








<a name="fig--2-2-11a"></a>
  
### <span style="color:#F21905">Fig. 2.2.11a</span> Main methods used to estimate TB mortality in HIV-negative people up to 2019

<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.11a-1.png" title="Main methods used to estimate TB mortality in HIV-negative people up to 2019" alt="Main methods used to estimate TB mortality in HIV-negative people up to 2019" width="1152" />
<div class="footnote"> IHME: Institute of Health Metrics and Evaluation, Seattle, USA. VR: Vital registration of causes of deaths.</div> 







<a name="fig--2-2-11b"></a>

### <span style="color:#F21905">Fig. 2.2.11b</span> Main methods used to estimate TB mortality in HIV-negative people in 2020

<img src="C:/Users/glazioup/Dropbox/gtb2021/report/html/ch2-2_files/figure-html/fig_2.2.11b-1.png" title="Main methods used to estimate TB mortality in HIV-negative people in 2020" alt="Main methods used to estimate TB mortality in HIV-negative people in 2020" width="1152" />

<div class="footnote"> VR: Vital registration of causes of deaths.</div> 







 
